When we blocked the DR-mediated increase in CBP and associated factors, we blocked all the protective effects of DR on lifespan extension, on the slowed rate of aging, and on protection against pathology in a model of Alzheimer's disease. This evidence concerns the gene CREBBP and early-onset autosomal dominant Alzheimer disease.